Former Merck and NASA Leaders Bring Strategic Expertise to SpaceMD Amid Rising Demand for its In-Space Pharmaceutical Development Capabilities

Business Wire· July 8, 2026

SpaceMD has appointed former executives from Merck and NASA to its leadership team to address the increasing demand for pharmaceutical development in microgravity environments. This move underscores the growing commercial interest in leveraging the unique conditions of space for advanced drug research and manufacturing. The addition of these strategic experts is expected to help the company navigate the technical and regulatory challenges of the burgeoning in-space bio-manufacturing sector.

Read the full story at Business Wire

Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to Business Wire.